CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		3,944,000
Beginning balance at Dec. 31, 2022	$ (2,066)	$ 0	$ 83,804	$ (85,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(22,037)			(22,037)
Issuance of warrants in connection with Credit Agreement amendment	4,060		4,060
Vesting of restricted stock units (in shares)		105,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(20,000)
Repurchases of restricted stock for payroll tax withholding	(318)		(318)
Stock-based compensation expense	5,678		5,678
Adjustment due to the rounding impact from the Reverse Stock Split in lieu of issuing fractional shares (in shares)		36,000
Ending balance (in shares) at Sep. 30, 2023		4,065,000
Ending balance at Sep. 30, 2023	(14,683)	$ 0	93,224	(107,907)
Beginning balance (in shares) at Jun. 30, 2023		4,021,000
Beginning balance at Jun. 30, 2023	(11,933)	$ 0	91,920	(103,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,054)			(4,054)
Vesting of restricted stock units (in shares)		12,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(4,000)
Repurchases of restricted stock for payroll tax withholding	(71)		(71)
Stock-based compensation expense	1,375		1,375
Adjustment due to the rounding impact from the Reverse Stock Split in lieu of issuing fractional shares (in shares)		36,000
Ending balance (in shares) at Sep. 30, 2023		4,065,000
Ending balance at Sep. 30, 2023	$ (14,683)	$ 0	93,224	(107,907)
Beginning balance (in shares) at Dec. 31, 2023	4,072,713	4,073,000
Beginning balance at Dec. 31, 2023	$ (27,992)	$ 0	94,544	(122,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(16,346)			(16,346)
Stock options exercised (in shares)		45,000
Stock options exercised	209		209
Vesting of restricted stock units (in shares)		143,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(38,000)
Repurchases of restricted stock for payroll tax withholding	(562)		(562)
Stock-based compensation expense	$ 4,428		4,428
Ending balance (in shares) at Sep. 30, 2024	4,222,722	4,223,000
Ending balance at Sep. 30, 2024	$ (40,263)	$ 0	98,619	(138,882)
Beginning balance (in shares) at Jun. 30, 2024		4,169,000
Beginning balance at Jun. 30, 2024	(32,946)	$ 0	97,048	(129,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,888)			(8,888)
Stock options exercised (in shares)		41,000
Stock options exercised	191		191
Vesting of restricted stock units (in shares)		21,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(8,000)
Repurchases of restricted stock for payroll tax withholding	(105)		(105)
Stock-based compensation expense	$ 1,485		1,485
Ending balance (in shares) at Sep. 30, 2024	4,222,722	4,223,000
Ending balance at Sep. 30, 2024	$ (40,263)	$ 0	$ 98,619	$ (138,882)